JNJ

Johnson & Johnson
NYSEHEALTHCAREDRUG MANUFACTURERS - GENERAL

Key Statistics

Market Cap
$556.77B
P/E Ratio
26.68
EPS
$8.67
Beta
0.26
52W High
$250.24
52W Low
$145.39
50-Day MA
$232.90
200-Day MA
$211.33
Dividend Yield
2.26%
Profit Margin
21.80%
Forward P/E
20.00
PEG Ratio
3.01

About Johnson & Johnson

Johnson & Johnson (J&J) is an American multinational corporation founded in 1886 that develops medical devices, pharmaceuticals, and consumer packaged goods. Its common stock is a component of the Dow Jones Industrial Average and the company is ranked No. 36 on the 2021 Fortune 500 list of the largest United States corporations by total revenue. Johnson & Johnson is one of the world's most valuable companies, and is one of only two U.S.-based companies that has a prime credit rating of AAA, higher than that of the United States government.

Official WebsiteUSAFY End: December

Fundamentals

Revenue (TTM)$96.36B
Gross Profit (TTM)$65.56B
EBITDA$34.33B
Operating Margin27.40%
Return on Equity26.40%
Return on Assets8.42%
Revenue/Share (TTM)$40.02
Book Value$33.73
Price-to-Book6.86
Price-to-Sales (TTM)5.78
EV/Revenue6.12
EV/EBITDA17.49
Quarterly Earnings Growth (YoY)-52.90%
Quarterly Revenue Growth (YoY)9.90%
Shares Outstanding$2.41B
Float$2.40B
% Insiders0.05%
% Institutions76.83%

Historical Volatility

HV 10-Day
15.43%
HV 20-Day
17.59%
HV 30-Day
18.76%
HV 60-Day
16.67%
HV Rank
81.3%

Volatility is currently contracting

Analyst Ratings

Consensus ($252.96 target)
5
Strong Buy
9
Buy
10
Hold
1
Strong Sell

More HEALTHCARE Stocks

Data last updated: 5/29/2026